Marcos Jessé Abrahão Silva | Cell Biology | Best Researcher Award

Published on by Cell Biologist

Mr. Marcos Jessé Abrahão Silva | Cell Biology | Best Researcher Award

Mr. Marcos Jessé Abrahão Silva, State University of Pará (UEPA), Brazil

Marcos Jessé Abrahão Silva is a Brazilian biomedical scientist and Ph.D. student at the State University of Pará (UEPA), specializing in immunogenetics and molecular biology. He holds a Bachelor’s in Biomedicine from UNAMA and a Master’s in Epidemiology and Health Surveillance from the Evandro Chagas Institute. Marcos has contributed to over 35 technical-scientific publications, including high-impact journals such as Frontiers in Immunology and Microorganisms, and has accumulated more than 260 citations. He’s a published author of multiple scientific books and a reviewer for prestigious journals like Current Microbiology. His research spans infectious diseases like COVID-19, leprosy, HIV, and bacterial resistance. As a member of Sigma Xi, his academic dedication has earned him editorial appointments and international collaborations, including with Tulane University. Currently, Marcos leads research on HIV prevention in vulnerable groups using innovative approaches via social media under the project “raprev.aids”.

Publication Profile:

Google Scholar

✅ Strengths for the Award:

  1. Strong Publication Record 📚
    Marcos has authored or co-authored over 35 scientific publications, with more than 20 in high-impact journals (JCR indexed) such as Frontiers in Immunology, Viruses, Microorganisms, and Genes—an exceptional record for a Ph.D. student.

  2. Global Citation Impact 🌍
    His Google Scholar h-index of 7, Scopus h-index of 7, and Web of Science h-index of 6—along with 260+ citations—reflect international academic recognition and influence.

  3. Multidisciplinary Research Expertise 🧬
    His work integrates epidemiology, immunogenetics, molecular biology, and bioinformatics, focusing on infectious diseases including COVID-19, HIV, leprosy, and paracoccidioidomycosis, which are highly relevant to global health.

  4. Editorial and Peer-Review Roles ✍️
    Marcos is a reviewer for top journals, including CURRENT MICROBIOLOGY, and serves on the editorial board of the International Journal of Genetics—demonstrating leadership in academic publishing.

  5. International and Institutional Collaboration 🤝
    He collaborates with respected institutions like Evandro Chagas Institute, Federal University of Ceará, and Tulane University, expanding the impact of his research across borders.

  6. Innovation in Health Communication 💡
    He is currently leading a social innovation project (raprev.aids) combining science, technology, and culture for HIV prevention among vulnerable populations using digital and artistic media—a model for translational science.

⚠️ Areas for Improvement:

  1. First-Author Leadership in Top-Tier Journals
    While co-authorship is strong, more consistent first-author publications in Q1 journals would further solidify his leadership in research.

  2. Patent Contributions & Industry Linkages
    Although experienced in academic research, strengthening links with biomedical industry or technology transfer (patents) could amplify his societal and commercial impact.

  3. Global Networking
    Participation in more international conferences or fellowships would further raise his visibility on the global scientific stage.

🎓 Education0:

Marcos Jessé Abrahão Silva’s academic foundation is rooted in Biomedicine, having completed his Bachelor’s degree at the University of the Amazon (UNAMA) from 2018 to 2021. Following this, he earned his Master of Science degree from the prestigious Evandro Chagas Institute (IEC) through the Postgraduate Program in Epidemiology and Health Surveillance (2021–2023). He is currently pursuing his Ph.D. in Parasitology Biology in the Amazon at the State University of Pará (UEPA). Additionally, he is specializing in Bioinformatics at the Federal Technological University of Paraná (UTFPR), expected to complete in 2025. His educational trajectory reflects a strong emphasis on translational research, infectious disease epidemiology, and molecular diagnostics. Marcos has also been inducted as an official member of Sigma Xi, The Scientific Research Honor Society, highlighting his academic and professional distinction. His interdisciplinary education supports his work in cutting-edge biomedical and public health research.

🧪 Experience:

Marcos Jessé has developed extensive research experience in immunogenetics, molecular biology, and epidemiology. He has actively participated in significant research projects, such as the Hansen’s Immunogenetic Study and COVID-19 response analysis in Brazil. Marcos has co-authored more than 35 scientific publications, including international peer-reviewed journals, and written chapters in academic books on infectious diseases. His roles have included principal investigator, project member, and scientific reviewer for journals like Current Microbiology. He also has experience in scientific consulting and is involved in translational research, particularly focusing on disease susceptibility genetics. Marcos collaborates with leading institutions like the Evandro Chagas Institute, Federal University of Ceará, and Tulane University. Beyond academic research, he contributes to community-based health innovation through HIV prevention projects involving social media outreach. He has served in editorial roles and has been recognized with international awards for his scientific contributions, making him a standout emerging researcher from the Global South.

🔍 Research Focus:

Marcos Jessé Abrahão Silva’s research centers on immunogenetics, infectious diseases, and molecular biology, with a special emphasis on diseases endemic to Brazil and the Amazon. He investigates the genetic factors influencing susceptibility to pathogens like Mycobacterium leprae, HIV-1, and SARS-CoV-2, often analyzing Single Nucleotide Polymorphisms (SNPs) and immune response mechanisms. His work aims to unravel how innate and adaptive immune pathways contribute to disease severity, particularly in viral and bacterial infections. Marcos has conducted systematic reviews and meta-analyses to clarify the epidemiological role of genetic polymorphisms. His recent focus includes a culturally innovative HIV prevention project, “raprev.aids,” integrating artistic and scientific communication via social networks. He is also active in studying antimicrobial resistance, such as in Pseudomonas aeruginosa. His research goal is to bridge laboratory science with public health practice, particularly in vulnerable populations across the Amazon and broader Latin America.

📚 Publications Top Notes:

  1. 🧫 Hyperinflammatory response in COVID-19: a systematic review – Viruses

  2. 🧠 Adaptive immunity to SARS-CoV-2 infection: A systematic review – Frontiers in Immunology

  3. 🧬 Innate immunity to SARS-CoV-2 infection: a review – Epidemiology & Infection

  4. 🧪 The Relationship between TLR3 rs3775291 Polymorphism and Infectious Diseases: A Meta-Analysis – Genes

  5. 🧫 The Association between CCL5/RANTES SNPs and Susceptibility to HIV-1 Infection: A Meta-Analysis – Viruses

  6. 🧬 The relationship between 896A/G (rs4986790) polymorphism of TLR4 and infectious diseases: A meta-analysis – Frontiers in Genetics

  7. 🦠 Endemic High-Risk Clone ST277 & SPM-1-Producing P. aeruginosa During COVID-19 in Brazil – Microorganisms

  8. 🧫 Prevalence of MβL-Producing P. aeruginosa in Brazil: A Meta-Analysis – Microorganisms

  9. 🐀 The Presence of Mycobacterium leprae in Wild Rodents – Microorganisms

  10. 🧬 Associations between TLR3 SNPs and COVID-19 in Belém-PA Professionals – Frontiers in Cellular and Infection Microbiology

🔍 Conclusion:

Marcos Jessé Abrahão Silva is an exceptionally promising early-career researcher whose contributions already surpass many peers at the same academic stage. His proven scientific output, international citation record, and commitment to public health innovation make him highly suitable for the Best Researcher Award. His research not only addresses local health challenges in the Amazon and Brazil but also contributes meaningfully to the global understanding of infectious diseases and immune responses.

Balbino Alarcón | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Balbino Alarcón | Cancer Cell Biology | Best Researcher Award

Prof. Dr. Balbino Alarcón , Consejo Superior de Investigaciones Científicas , Spain

Balbino Alarcón is a leading Spanish immunologist renowned for his contributions to T cell biology and immune signaling. Currently serving as Profesor de Investigación at the Consejo Superior de Investigaciones Científicas (CSIC), he has been affiliated with the Centro de Biología Molecular Severo Ochoa since 2002. His research has played a pivotal role in uncovering mechanisms of T cell receptor (TCR) signaling and immune system regulation. Dr. Alarcón holds a PhD in Biology from the Universidad Autónoma de Madrid, where he began shaping his scientific journey in the early 1980s. Over the decades, he has authored numerous impactful publications, many in top-tier journals, and holds several patents licensed to biotech companies. His work bridges fundamental immunology with translational applications in autoimmunity and cancer. With a keen focus on molecular signaling, his research continues to influence both basic science and therapeutic innovation in immunology.

Publication Profile:

Google Scholar

✅ Strengths for the Award:

  1. Outstanding Research Contributions:
    Dr. Alarcón has made seminal contributions to immunology, especially in T cell receptor (TCR) signaling, immune synapse formation, and immune cell communication. His work has appeared in top-tier journals like Cell, Immunity, Nature Communications, and Journal of Experimental Medicine.

  2. Impactful Publications & Citations:
    His research includes several highly cited papers (e.g., >500 citations), underlining the influence of his work on the broader scientific community.

  3. Translational Achievements:
    He holds multiple patents on immunomodulatory molecules (e.g., AX-024), which were licensed to biotech company Artax Biopharma, bridging basic science and clinical application.

  4. SARS-CoV-2 Research Leadership:
    He actively contributed to COVID-19 immunity research, developing flow cytometry-based antibody detection techniques and tracking longitudinal immune responses to infection and vaccination.

  5. Longevity and Commitment:
    Over 40 years of consistent research activity, with continuous affiliation to one of Spain’s most prestigious scientific institutions, CSIC.

  6. International Collaboration:
    He co-authored papers with leaders in immunology, showing global recognition and collaboration.

🛠️ Areas for Improvement:

  • Public Engagement & Visibility:
    Despite scientific acclaim, more visibility in public science communication, conference keynote roles, or leadership in global immunology consortia would further support his candidacy.

  • Mentorship Highlighting:
    While his academic stature suggests mentorship, documentation or awards for training young scientists could enhance his profile for broader awards recognizing holistic impact.

  • Innovation Metrics:
    Increased emphasis on clinical translation or successful product development from his patents could strengthen claims to innovation-driven recognitions.

🎓 Education:

Dr. Balbino Alarcón completed his undergraduate degree (Licenciado en Biología) in 1982 and his PhD in Biology with a specialization in Biochemistry in 1985, both from the Universidad Autónoma de Madrid, Spain. During his academic formation, he developed a deep interest in immunological signaling, particularly in how T cells communicate with their environment. His early education laid the foundation for a distinguished research career that has spanned more than three decades. His doctoral studies were focused on cellular and molecular immunology, equipping him with the tools to explore intricate signaling pathways. This robust educational background positioned him for leadership roles in immunological research, both nationally and internationally. Through rigorous academic training and continuous research contributions, Dr. Alarcón has become a key figure in advancing our understanding of T cell function and immune regulation.

👨‍🔬 Experience:

Dr. Balbino Alarcón has over 40 years of experience in immunological research, with a primary focus on T cell receptor (TCR) signaling and lymphocyte activation. Since July 27, 2002, he has held the position of Profesor de Investigación at the Consejo Superior de Investigaciones Científicas (CSIC), working at the Centro de Biología Molecular Severo Ochoa in Madrid, Spain. His academic and research career began with groundbreaking studies in T cell immunobiology, leading to discoveries such as the role of conformational changes in TCR activation. Dr. Alarcón has also been deeply involved in translational research, co-developing immunomodulatory drugs and securing patents that were licensed to Artax Biopharma. He regularly collaborates with leading immunologists and institutions worldwide, contributing to high-impact publications and international scientific reviews. His expertise and sustained contributions have made him a mentor and authority in molecular immunology and T cell biology.

🏅 Awards and Honors:

Dr. Balbino Alarcón’s distinguished career is highlighted by several prestigious awards and intellectual property recognitions. He co-developed two patented immunosuppressive strategies based on TCR signaling inhibition: one disrupting the TCR-Nck interaction and another involving chromene derivatives. Both patents were licensed to Artax Biopharma, showcasing the real-world therapeutic relevance of his research. He has authored highly cited publications, including foundational work published in Cell, Immunity, and Annual Review of Immunology, with citations in the hundreds. These contributions have not only advanced the field of immunology but also positioned Dr. Alarcón as a thought leader in immune signal transduction. He has been recognized nationally and internationally for his scientific achievements, serving as an editorial contributor and co-author of influential immunological reviews. His work continues to shape both academic and pharmaceutical research, making him a strong candidate for Best Researcher Awards.

🔬 Research Focus:

Dr. Alarcón’s research centers on the molecular mechanisms governing T cell receptor (TCR) activation and signal transduction. His work dissects how T cells recognize antigens and how intracellular signaling cascades translate these interactions into immune responses. A significant aspect of his research has involved understanding the conformational dynamics of the TCR/CD3 complex and how this affects T cell sensitivity and activation thresholds. He also explores the role of RRas2 in T and B cell function, including its relevance in lymphomagenesis and autoimmunity. Recently, he has contributed to understanding immune responses to SARS-CoV-2 and methods to detect neutralizing antibodies. His interdisciplinary approach integrates cell biology, molecular immunology, and translational research, linking fundamental science to clinical applications such as vaccine development and immunotherapy. By targeting TCR-associated pathways, Dr. Alarcón’s research opens new avenues in the treatment of immune-related diseases and cancer.

📚 Publications Top Notes:

  1. 🧫 RRas2 is required for germinal center formation to aid B cells during energetically demanding processes (Sci Signal, 2018)

  2. 🧪 A window of opportunity for cooperativity in the T Cell Receptor (Nat Commun, 2018)

  3. 🧬 Antigen phagocytosis by B cells is required for a potent humoral response (EMBO Rep, 2018)

  4. ⚙️ RRAS2 shapes the TCR repertoire by setting the threshold for negative selection (J Exp Med, 2019)

  5. 💊 Small molecule AX-024 targets T cell receptor signaling by disrupting CD3ε-Nck interaction (J Biol Chem, 2020)

  6. 🧪 Flow cytometry multiplexed method for the detection of Neutralizing human antibodies to SARS-CoV-2 (EMBO Mol Med, 2021)

  7. 🧬 Antigen presentation between T-cells drives Th17 polarization under limiting antigen (Cell Rep, 2021)

  8. 🧫 Detection of sustained humoral immune response (IgG + IgA) in SARS-CoV-2 infection (Sci Rep, 2021)

  9. 🧠 SFRP1 modulates astrocyte-to-microglia crosstalk in neuroinflammation (EMBO Rep, 2021)

  10. 💉 Longitudinal dynamics of SARS-CoV-2-specific immunity after infection or vaccination (PLoS Pathog, 2021)

🧾 Conclusion:

Dr. Balbino Alarcón is a highly deserving candidate for the Best Researcher Award. His pioneering studies in T cell signaling, impactful biomedical patents, and active role in immune response to infectious diseases demonstrate excellence in both basic and translational immunology. With decades of productive research, interdisciplinary collaboration, and consistent scientific leadership, he embodies the qualities celebrated by such an award.

Allegra Wundersitz | Signal Transduction Mechanisms | Young Scientist Award

Published on by Cell Biologist

Mrs. Allegra Wundersitz | Signal Transduction Mechanisms | Young Scientist Award

Mrs. Allegra Wundersitz , RWTH Aachen University, Molekulare Ökologie der Rhizosphäre , Germany

Allegra Wundersitz is a passionate molecular biologist currently pursuing her PhD at RWTH Aachen University, Germany, in the group of Molecular Ecology of the Rhizosphere. Her research delves into the molecular mechanisms of plant oxygen sensing and the regulatory role of acyl-CoA-binding proteins (ACBPs) in stress signaling. Allegra has been recognized for her academic excellence, receiving the ISPA Poster Award and the Best Botanic Master’s Thesis Award from the German Society for Plant Sciences (DBG). With expertise in cloning, yeast-two-hybrid, luciferase complementation, and computational modeling, she seamlessly integrates biochemical and molecular approaches. Allegra actively collaborates with interdisciplinary teams, bridging plant physiology, structural biology, and molecular dynamics. Her commitment to research and mentoring makes her a promising young scientist aiming to contribute not only to fundamental plant science but also to translational applications in health and agriculture.

Publication Profile:

Orcid

✅ Strengths for the Award:

  • Innovative Research Focus: Allegra’s work on acyl-CoA-binding proteins (ACBPs) in plant oxygen sensing and stress signaling demonstrates high originality. Her approach of integrating protein biochemistry, gene regulation, and computational modeling is both novel and impactful.

  • Early Recognition: Despite being in the early stages of her career, she has received notable honors, including the ISPA Poster Award and the Best Master’s Thesis Award (DBG)—highlighting the quality and relevance of her work.

  • Interdisciplinary Collaboration: She engages with experts in molecular dynamics and structural biology, enriching her research with advanced modeling of protein mutations—showing strong collaborative and technical competencies.

  • Mentorship & Leadership: Supervising undergraduate students showcases her commitment to academic development and science communication.

  • Publication Record: Her first peer-reviewed article in New Phytologist indicates strong potential for growing her scientific influence.

🧩 Areas for Improvement:

  • Professional Engagement: Joining relevant scientific societies or organizations could enhance her visibility, offer networking opportunities, and provide access to grants or awards.

  • Industry Exposure: While her current focus is on basic science, even limited engagement with applied research or biotechnology partnerships could broaden the translational scope of her work.

  • Publication Volume: As her research matures, expanding her publication record beyond reviews into primary experimental studies will strengthen her academic profile.

🎓 Education:

Allegra Wundersitz holds a Master’s degree in Plant Molecular Biology, where her thesis on acyl-CoA-binding proteins (ACBPs) earned national recognition by the German Society for Plant Sciences in 2024. She is currently a PhD student at RWTH Aachen University, Germany, specializing in the molecular ecology of the rhizosphere. Her academic training spans core fields such as structural biochemistry, plant physiology, and gene regulation. Through hands-on learning and international workshops, she has developed technical proficiency in protein interaction assays, biosensor design, and in silico modeling. Her education emphasizes a multidisciplinary approach, blending experimental and computational biology. She has also supervised undergraduate research projects, further strengthening her academic leadership. Allegra’s educational journey reflects her deep curiosity for understanding molecular mechanisms in plant biology and their broader implications.

🧪 Experience:

Allegra’s experience is rooted in academic molecular biology research. During her Master’s and now as a PhD candidate, she has completed two significant research projects: developing plant-based oxygen biosensors and exploring the role of ACBPs in gene regulation. Her current PhD project investigates how ACBPs act as acyl-CoA receptors, mediating responses to oxygen and stress in plants. She employs techniques such as yeast two-hybrid assays, luciferase complementation, cloning, and molecular modeling. Allegra has also collaborated with experts in molecular dynamics, including Prof. Maria Fyta and Dr. Chandan Das, to simulate structural effects of ACBP mutations. She has presented her work at international conferences and received a prestigious poster award at ISPA. Allegra is gaining valuable teaching experience through undergraduate supervision, making her a well-rounded early-career scientist. Though she has not yet worked in industry, her work holds potential translational value in agriculture and health.

🔍 Research Focus:

Allegra’s research centers on the role of acyl-CoA-binding proteins (ACBPs) as key molecular players in plant oxygen sensing and stress signaling. She investigates how ACBPs function as acyl-CoA receptors and modulate gene expression through dynamic protein-protein interactions. Her goal is to uncover how lipid signals like acyl-CoAs are translated into physiological responses under stress conditions. Using a combination of experimental techniques—such as cloning, luciferase complementation assays, yeast-two-hybrid screens—and computational molecular dynamics, she deciphers the structural and functional aspects of ACBP interactions. Her research not only expands fundamental plant molecular biology but also contributes insights with potential applications in crop resilience, metabolic regulation, and even human health, given ACBPs’ links to cancer and metabolic disorders. Through interdisciplinary collaboration, Allegra aims to bridge structural biochemistry and plant physiology to understand how cells adapt to fluctuating oxygen and energy levels.

📚 Publications Top Notes:

  • 🧬 Acyl-CoA-binding proteins: bridging long-chain acyl-CoA metabolism to gene regulation – Tansley Insight, New Phytologist (April 22, 2025)

🧾 Conclusion:

Allegra Wundersitz is a highly promising young researcher who combines technical excellence, creativity, and interdisciplinary integration in her approach to plant molecular biology. Her foundational work on ACBPs not only deepens our understanding of plant stress responses but also hints at broader implications in health and metabolic research. With her trajectory and dedication, she is an ideal candidate for the Young Scientist Award, and this recognition would further support her impactful scientific journey.